We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > MicuRx

News List

China NMPA Approves MicuRx's Contezolid for Treatment of Drug-Resistant Bacterial Infection prnasia
June 04, 2021
MicuRx Pharmaceutical Co., Ltd. announced that China National Medical Products Administration (NMPA) has approved its new drug application for contezolid as the treatment of complicated skin and soft tissue infection.
MicuRx Commits Funding for Development of MRX-8 americanpharmaceuticalreview
August 18, 2020
MicuRx Pharmaceuticals announced the global partnership Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) has committed up to US$7.78 million of nondilutive financing for a Phase 1 clinical trial and related R&D activities ...
MicuRx Announces Closing of ¥100 Million Funding prnasia
December 08, 2017
MicuRx Pharmaceuticals, Inc. today announced closing of ¥100 million private financing led by Chinese affiliates of the existing MicuRx investors Delian Capital and BVCF